Gene set enrichment analysis (GSEA) showed that several crucial cancer hallmark signatures were enriched in KMT2D-KO SCC23 cells, including glycolysis, mTORC1 signaling, MYC targets, and ribosome biogenesis (Fig. 2d–g). This evidence concerns the gene KMT2D and cancer.